Literature DB >> 6736868

Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice.

A Rifai, M Mannik.   

Abstract

To characterize the physiology of circulating IgA immune complexes (IgA-IC), the dynamics of IgA-IC removal by the liver were examined. After intravenous injection, covalently cross-linked IgA antibodies to the dinitrophenyl determinant were rapidly removed from the circulation by the liver. Immunofluorescence microscopy and light and electron microscope autoradiography showed that the IgA-IC were associated with Kupffer cells. With increasing doses of injected IgA-IC the clearance velocity approached a maximum, thus prolonging the circulation of IgA-IC. All these observations indicated a receptor-mediated process. Saturating doses of various potential receptor-blocking agents, heat-aggregated mouse IgG, microaggregated human serum albumin, and purified dimeric IgA did not influence the clearance pattern and hepatic uptake of radiolabeled IgA-IC. Mouse livers were also perfused via the portal vein with 1 microgram of IgA-IC. In the presence or absence of serum proteins, 43% of the perfused IgA-IC were removed in a single passage. This liver uptake was not reduced with simultaneous perfusion of large doses of aggregated mouse IgG, aggregated human serum albumin, or purified free dimeric mouse IgA. In contrast, the liver uptake of radiolabeled IgA-IC was decreased by 88% with the addition of 1 mg unlabeled IgA-IC. These observations support the conclusion that removal of IgA-IC from circulation is mediated by a specific IgA receptor on Kupffer cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736868      PMCID: PMC2187430          DOI: 10.1084/jem.160.1.125

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

2.  In vivo and in vitro binding of IgA to the plasma membrane of hepatocytes.

Authors:  U Hopf; P Brandtzaeg; T H Hütteroth; K H Meyer zum Büschenfelde
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

Review 3.  Endocytosis.

Authors:  S C Silverstein; R M Steinman; Z A Cohn
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

4.  Experimental model for IgA nephropathy.

Authors:  K Isaacs; F Miller; B Lane
Journal:  Clin Immunol Immunopathol       Date:  1981-09

Review 5.  Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors.

Authors:  J C Unkeless; H Fleit; I S Mellman
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

6.  Effect of circulating immune complexes on Fc and C3 receptors of Kupffer cells in vivo.

Authors:  T Nishi; A K Bhan; A B Collins; R T McCluskey
Journal:  Lab Invest       Date:  1981-05       Impact factor: 5.662

7.  Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.

Authors:  A Rifai; M Mannik
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  IGA in human bile and liver.

Authors:  H Nagura; P D Smith; P K Nakane; W R Brown
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

9.  Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.

Authors:  G Pfaffenbach; M E Lamm; I Gigli
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Secretory component as the receptor for polymeric IgA on rat hepatocytes.

Authors:  E Orlans; J Peppard; J F Fry; R H Hinton; B M Mullock
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  26 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.

Authors:  J González-Cabrero; J Egido; A Barat; E González
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 3.  IgA nephropathy: clearance kinetics of IgA-containing immune complexes.

Authors:  Ann Chen; Sung-Sen Yang; Tsai-Jung Lin; Shuk-Man Ka
Journal:  Semin Immunopathol       Date:  2018-09-14       Impact factor: 9.623

4.  Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells.

Authors:  W Emlen; A Rifai; D Magilavy; M Mannik
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

5.  Clearance kinetics and tissue distribution of aggregated human serum IgA in rats.

Authors:  W M Bogers; A Gorter; M E Stuurman; L A Van Es; M R Daha
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

6.  Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA.

Authors:  A Rifai; K Millard
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

7.  Circulating IgA immune complexes and skin IgA deposits in liver disease. Relation to liver histopathology.

Authors:  A van de Wiel; R M Valentijn; H J Schuurman; M R Daha; R J Hené; L Kater
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

8.  The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA.

Authors:  C S Kaetzel; J K Robinson; K R Chintalacharuvu; J P Vaerman; M E Lamm
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells.

Authors:  W M Bogers; R K Stad; D J Janssen; N van Rooijen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

10.  Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.

Authors:  W Emlen; V Carl; G Burdick
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.